ArticleFrontiers in medicine2026
The impact of nutritional intervention on the prognosis of PCOS patients with different BMIs.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women, often associated with metabolic abnormalities and ovulatory dysfunction. This study aimed to assess the effect of body mass index (BMI) and its interactions on nutritional intervention outcomes in PCOS patients. Methods and study design: A total of 360 PCOS patients were retrospectively analyzed. Ovulation rates and metabolic indices before and after treatment were compared across BMI groups. A multivariate regression analysis was used to assess the influence of BMI, age, symptom duration, family history, and ovarian enlargement on intervention outcomes. Interaction effects between BMI and other variables were also examined. Results: After treatment, ovulation rates, homeostasis model assessment of insulin resistance (HOMA-IR), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and fasting plasma glucose (FPG) improved significantly in all groups, with the obese group showing the greatest BMI reduction (-5.8%) and most favorable response. A multivariate analysis indicated that poorer outcomes were associated with older age (odds ratio (OR) = 0.993), longer symptom duration (OR = 0.982), a family history of PCOS (OR = 0.745), ovarian enlargement (OR = 0.887), and a higher number of ovarian cysts (OR = 0.882). Conversely, higher BMI (OR = 1.089) and HDL (OR = 1.010) were associated with better outcomes. Interaction analysis revealed that age attenuated the positive effect of BMI (OR = 0.992), and ovarian enlargement further diminished BMI's beneficial impact (OR = 0.759). Conclusion: Obese patients derived the greatest benefit from nutritional intervention. Higher BMI was associated with better outcomes, particularly among younger patients and those with less ovarian enlargement. These findings support the use of personalized nutrition strategies to enhance treatment efficacy in PCOS management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.